Literature DB >> 34315745

Utility of Ct values in differentiating COVID-19 reinfection versus prolonged viral shedding in an immunocompromised patient.

Katherine Julian1, Neal Shah2, Rashmi Banjade3, Dhirisha Bhatt4.   

Abstract

We describe the case of a 26-year-old man who presented to an outside hospital with concerns of blurred vision. He subsequently tested positive for COVID-19 and his lab work suggested acute leukaemia. The patient was admitted to our hospital and completed a course of remdesivir. He eventually tested negative for COVID-19 before initiating chemotherapy. Two days after starting chemotherapy, he developed a neutropenic fever and tested positive for COVID-19. Through this case, we aim to bring attention to patients who recurrently test positive with COVID-19 PCR testing, thereby causing a dilemma of differentiating between reinfections and prolonged shedding of the virus, as well as understand and use cycle threshold values to discern these aetiologies. © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  haematology (incl blood transfusion); infectious diseases

Year:  2021        PMID: 34315745     DOI: 10.1136/bcr-2021-243692

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  2 in total

1.  Comparative Evaluation of Six SARS-CoV-2 Real-Time RT-PCR Diagnostic Approaches Shows Substantial Genomic Variant-Dependent Intra- and Inter-Test Variability, Poor Interchangeability of Cycle Threshold and Complementary Turn-Around Times.

Authors:  Rok Kogoj; Misa Korva; Nataša Knap; Katarina Resman Rus; Patricija Pozvek; Tatjana Avšič-Županc; Mario Poljak
Journal:  Pathogens       Date:  2022-04-12

2.  Occurrence of SARS-CoV-2 reinfections at regular intervals in Ecuador.

Authors:  Rommel Guevara; Belén Prado-Vivar; Sully Márquez; Erika B Muñoz; Mateo Carvajal; Juan José Guadalupe; Mónica Becerra-Wong; Stefanie Proaño; Rosa Bayas-Rea; Josefina Coloma; Michelle Grunauer; Gabriel Trueba; Patricio Rojas-Silva; Verónica Barragán; Paúl Cárdenas
Journal:  Front Cell Infect Microbiol       Date:  2022-09-09       Impact factor: 6.073

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.